Beddingfield III Frederick 4
4 · Sienna Biopharmaceuticals, Inc. · Filed Feb 26, 2019
Insider Transaction Report
Form 4
Beddingfield III Frederick
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2019-02-22$2.50/sh+40,000$100,000→ 831,662 total
Holdings
- 112,614(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]The Reporting Person purchased the shares of the Issuer's common stock in connection with the Issuer's public offering at the offering price of $2.50 per share.
- [F2]The shares are directly held by the Beddingfield Family Trust.